Saints Sages Surgical embarks on a defining year of global growth at WHX with next-generation surgical energy solutions

DUBAI, UAE – During a successful exhibition at WHX 2026, Saints Sages Surgical is proud to announce that 2026 has become a pivotal turning point in our mission to revolutionize global surgical energy solutions. The event served as a high-profile stage to showcase our focus on large-scale international growth.

A Milestone in Regulatory Excellence

The core of this year’s momentum is the successful EU MDR certification of our flagship platforms:

●The SA100 Dual-Energy Fusion Platform stands as a global pioneer in surgical technology, offering a sophisticated dual-channel system that redefines operating room efficiency. By facilitating seamless switching between ultrasonic and advanced bipolar modules, the SA100 removes the logistical burden of repeatedly swapping instruments. This "all-in-one" capability allows surgical teams to address diverse intraoperative energy requirements through a single, integrated platform. Beyond its versatility, the SA100 is anchored by two breakthrough proprietary technologies: RTTE II (Real-Time Tissue Adaptive Technology) and MPTS (Multi-Pulse Tissue Sensing Technology). These systems provide intelligent, real-time adjustments that have been clinically validated to securely coagulate vessels up to 7mm.

●The SA10 Portable Ultrasonic Soft Tissue Cutting and Hemostasis Device redefines surgical mobility by featuring the world’s first controller as compact as a mobile phone. This highly integrated design drastically reduces the footprint in the operating room. By unifying into a single, cohesive unit, the SA10 ensures the transducer maintains peak performance through regular use, eliminating the complexities of traditional setups.

●The SP10 stands as the world’s first portable advanced bipolar solution, fundamentally transforming the portability standards of traditional energy devices. Despite its palm-sized frame, it houses a formidable energy core driven by the MPTS artificial intelligence algorithm. This system intelligently adapts to diverse tissue types to achieve stable coagulation of 7mm large vessels, while significantly minimizing surgical smoke and tissue adhesion.

These certifications, coupled with ongoing registrations in key global markets, validate Saints Sages Surgical’s rigorous R&D standards and long-term commitment to international regulatory compliance.

Meaningful Connections & Shared Visions

Our booth in Dubai became a vibrant hub of activity, and we are profoundly grateful to all our long-time partners and new friends who visited us. The event was defined by meaningful conversations, hands-on product experiences, and shared visions for the future of surgical energy.

Seeing surgeons, distributors, and industry peers engaging directly with our SA10, SA100, and SP10 platforms—exchanging feedback and enthusiasm—was truly inspiring. These interactions reinforce our belief that through differentiated technology and strong collaboration, we will continue opening new possibilities for our global partners.

Beyond Products: Empowering Surgeons Globally

"We are not simply launching products; we are building next-generation surgical energy platforms," the company stated in Dubai. By integrating ultrasonic and advanced bipolar technologies, Saints Sages Surgical empowers surgeons with greater precision, efficiency, and confidence in the operating room.

2026: Execution, Expansion, and Impact

From Dubai to Europe and beyond, 2026 is defined by execution and impact. We are working alongside our partners to expand access to high-performance surgical energy solutions, ensuring that advanced medical technology reaches more patients worldwide.

As we move forward, Saints Sages Surgical remains dedicated to its journey of clinical excellence. We look forward to continuing this path with our global community, shaping the future of surgical intervention together.